| Date Filed | Type | Description |
| 08/14/2023 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 06/13/2022 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 100,000 options to buy
@ $0.43, valued at
$43k
|
|
| 06/10/2022 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 06/15/2021 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9877, valued at
$39.5k
|
|
| 06/02/2021 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 68,577 options to buy
@ $1.74, valued at
$119.3k
|
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2020 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 64,103 options to buy
@ $1.05, valued at
$67.3k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 46,500 options to buy
@ $0.64, valued at
$29.8k
|
|
| 06/14/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $0 |
|
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/06/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.38, valued at
$56.3k
Granted 3,000 restricted stock units
@ $0 |
|
| 05/16/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
| 06/14/2018 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $9.95, valued at
$59.7k
Granted 3,000 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0 |
|
| 05/17/2018 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 30,000 options to buy
@ $1.84, valued at
$55.2k
|
|
| 06/15/2017 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 6,000 options to buy
@ $28.01, valued at
$168.1k
Granted 3,000 restricted stock units
@ $0 |
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2016 |
4/A
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 10,344 options to buy
@ $28.82, valued at
$298.1k
|
|
| 06/23/2016 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 10,344 options to buy
@ $28.82, valued at
$298.1k
|
|
| 05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/25/2012 |
3
| Nunn Jason Raleigh (Director) has filed a Form 3 on HYPERION THERAPEUTICS INC |
| 01/26/2012 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 7,000 options to buy
@ $8.18, valued at
$57.3k
|
|
| 01/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/02/2009 |
3
| Nunn Jason Raleigh (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |